PROMATIX BIOSCIENCES LTD

Executive Summary

PROMATIX BIOSCIENCES LTD exhibits high solvency risk due to a substantial increase in long-term liabilities and a shift to negative net assets in the latest financial year. While regulatory compliance is up to date and operational headcount is increasing, the sharp deterioration in financial metrics warrants further investigation into liquidity management and creditor arrangements. Investors should closely examine the sustainability of the company’s capital structure and cash flow outlook before committing capital.

View Full Analysis Report →
Company Documents

DateDescription
27/08/2527 August 2025 NewConfirmation statement made on 2025-08-24 with no updates

View Document

16/06/2516 June 2025 Change of details for Mr Alek Safarian as a person with significant control on 2025-04-06

View Document

16/06/2516 June 2025 Director's details changed for Mr Alek Safarian on 2025-04-06

View Document

31/03/2531 March 2025 Micro company accounts made up to 2024-12-31

View Document

31/12/2431 December 2024 Annual accounts for year ending 31 Dec 2024

View Accounts

14/10/2414 October 2024 Appointment of Dr Graeme Richard Martin as a director on 2024-10-14

View Document

29/08/2429 August 2024 Confirmation statement made on 2024-08-24 with updates

View Document

04/07/244 July 2024 Memorandum and Articles of Association

View Document

27/06/2427 June 2024 Statement of capital following an allotment of shares on 2024-05-21

View Document

13/05/2413 May 2024 Registration of charge 135854000001, created on 2024-05-09

View Document

07/02/247 February 2024 Micro company accounts made up to 2023-12-31

View Document

31/12/2331 December 2023 Annual accounts for year ending 31 Dec 2023

View Accounts

24/08/2324 August 2023 Confirmation statement made on 2023-08-24 with updates

View Document

09/05/239 May 2023 Current accounting period extended from 2023-08-31 to 2023-12-31

View Document

18/04/2318 April 2023 Statement of capital following an allotment of shares on 2023-04-18

View Document

31/01/2331 January 2023 Appointment of Dr Robert Henry Balfour as a director on 2023-01-23

View Document

07/12/227 December 2022 Micro company accounts made up to 2022-08-31

View Document

31/08/2231 August 2022 Annual accounts for year ending 31 Aug 2022

View Accounts

05/05/225 May 2022 Statement of capital following an allotment of shares on 2022-04-25

View Document


More Company Information


Follow Company
  • Receive an alert email on changes to financial status
  • Early indications of liquidity problems
  • Warns when company reporting is overdue
  • Free service, no spam emails
  • Follow this company